Cargando…

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Chen, Yaxin, Xia, Lei, Peng, Yuxuan, Wang, Gang, Bi, Liyun, Xiao, Xue, Li, Cui, Li, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660251/ https://www.ncbi.nlm.nih.gov/pubmed/38023249 http://dx.doi.org/10.3389/fonc.2023.1309950

Ejemplares similares

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Identification and validation of m6A-GPI signatures as a novel prognostic model for colorectal cancer
por: Ma, Bin, et al.
Publicado: (2023)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics
por: Li, Huijun, et al.
Publicado: (2022)

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
por: Li, Jingyang, et al.
Publicado: (2022)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
por: Mu, Teng, et al.
Publicado: (2022)

Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer
por: Chen, Kang, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of m(6)A Genes in Nasopharyngeal Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2020)

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
por: Li, Zijian, et al.
Publicado: (2022)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures
por: Lu, Fei, et al.
Publicado: (2022)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer
por: Wang, Haixu, et al.
Publicado: (2021)

Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing
por: Mao, Wenli, et al.
Publicado: (2022)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Prognostic and Predictive Value of m6A “Eraser” Related Gene Signature in Gastric Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods
por: Li, Xia, et al.
Publicado: (2021)

Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma
por: Zhou, Xuanchen, et al.
Publicado: (2020)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5
por: Ji, Tiannan, et al.
Publicado: (2023)

Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma
por: Ma, Yi, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2023)

Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study
por: Yang, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pa2sq6jmrmsfav6qmsg40lico5